Spots Global Cancer Trial Database for ly3295668 erbumine
Every month we try and update this database with for ly3295668 erbumine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body | NCT03955939 | Metastatic Brea... | LY3295668 Erbum... Endocrine thera... Midazolam | 18 Years - | Eli Lilly and Company | |
| A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body | NCT03955939 | Metastatic Brea... | LY3295668 Erbum... Endocrine thera... Midazolam | 18 Years - | Eli Lilly and Company | |
| A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma | NCT04106219 | Neuroblastoma | LY3295668 Erbum... Topotecan Cyclophosphamid... | 2 Years - 21 Years | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
